Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease.

Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease.
复制标题

DOI:
10.1177/1535370214523890
复制
发表时间:
2014-11
期刊:
Experimental biology and medicine (Maywood, N.J.)
影响因子:
--
通讯作者:
James J
James J
中科院分区:
其他
文献类型:
--
作者:
Cantorna MT;McDaniel K;Bora S;Chen J;James J

文献摘要

参考文献

被引文献

相似文献

炎症性肠病(IBD)是由环境、免疫和遗传因素引起的复杂疾病。IBD患者的维生素D状态较低,而实验性IBD在维生素D缺乏或维生素D受体敲除动物中更为严重。维生素D对IBD有益,因为它调节肠道内稳态所必需的多个检查点和过程。维生素D抑制IFN-γ和IL-17的产生,同时诱导调节性T细胞。此外,维生素D调节上皮细胞的完整性,先天免疫反应和肠道微生物群的组成。总体而言,维生素D调节维持胃肠道稳态的多种途径。数据支持改善IBD患者的维生素D状态。
The inflammatory bowel diseases (IBD) are complex diseases caused by environmental, immunological and genetic factors. Vitamin D status is low in patients with IBD and experimental IBD is more severe in vitamin D deficient or vitamin D receptor knockout animals. Vitamin D is beneficial in IBD because it regulates multiple checkpoints and processes essential for homeostasis in the gut. Vitamin D inhibits IFN-γ and IL-17 production while inducing regulatory T cells. In addition, vitamin D regulates epithelial cell integrity, innate immune responses, and the composition of the gut microbiota. Overall vitamin D regulates multiple pathways that maintain gastrointestinal homeostasis. The data support improving vitamin D status in patients with IBD.
DOI: 10.1053/j.gastro.2010.07.006
发表时间: 2010-11
期刊: Gastroenterology
影响因子: 29.4
作者:
Homer CR;Richmond AL;Rebert NA;Achkar JP;McDonald C
通讯作者: McDonald C
DOI: 10.1096/fj.04-3284com
发表时间: 2005-07-01
期刊: FASEB JOURNAL
影响因子: 4.8
作者:
Gombart, AF;Borregaard, N;Koeffler, HP
通讯作者: Koeffler, HP
DOI: 10.1111/j.1365-2036.2010.04355.x
发表时间: 2010-08-01
影响因子: 7.6
作者:
Jorgensen, S. P.;Agnholt, J.;Dahlerup, J. F.
通讯作者: Dahlerup, J. F.
DOI: 10.1016/j.abb.2011.11.001
发表时间: 2012-07-01
影响因子: 3.9
作者:
Cantorna, Margherita T.
通讯作者: Cantorna, Margherita T.
DOI: 10.1073/pnas.0831037100
发表时间: 2003-04-29
影响因子: 11.1
作者:
Das, G;Augustine, MM;Ray, A
通讯作者: Ray, A